Alphora Research provides API technology development services for the scale up of complex small molecules with pharmaceutical applications
Alphora's services include process/analytical development and validation, stability testing and cGMP synthesis. Alphora's 25,000 sq.ft. facility includes cGMP Kilo Labs, Pilot Plant operations and organic and analytical labs. Alphora combines excellence and creativity in synthetic organic chemistry with a sound scientific approach to analytical development for novel API technology. It is the application of this combined approach, with a long term view of the program requirements that ensures the clients' clinical and commercial success.
Founded by Dr. Jan Oudenes, Alphora has established an enthusiastic and committed management team with over 100 years of combined experience and notable success in developing and successfully implementing API technologies for hundreds of pre-clinical and clinical compounds.
Visit our stand: Booth 1240